Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Selling to Employers
All Newsletters
93 articles
9 of 10
Livongo’s IPO anniversary. DTx pipelines.
7.24.20
7
min. Read
Haven’s health coach partner went public. French reimbursement.
6.12.20
6
min. Read
M&A: Omada-Physera. Optum-AbleTo. Elekta-Kaiku.
5.22.20
6
min. Read
Why Omada Health should buy Physera and other MSK M&A digital health predictions
5.16.20
5
min. Read
Livongo: 10 percent utilization uptick. $215M RWE acquisition.
4.10.20
6
min. Read
RCT shows no effect for AI coach. Livongo ups enrollment rate.
3.06.20
8
min. Read
Strip companies tried to kill Livongo. Sanofi DTx distro.
2.28.20
8
min. Read
Omada hits 275K cumulative users. More on Pear, Limbix, ATX.
9.19.19
5
min. Read
Livongo’s beyond diabetes revenue. Fitbit loses exec to CVS-Aetna
9.06.19
3
min. Read
Quick data scan on federal contracts. Rethinking platform strategies.
8.30.19
5
min. Read
1 of 10